{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T19:42:10Z","timestamp":1765827730688,"version":"build-2065373602"},"reference-count":84,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.dld.2018.11.016","type":"journal-article","created":{"date-parts":[[2018,11,28]],"date-time":"2018-11-28T12:15:31Z","timestamp":1543407331000},"page":"183-189","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Chronic hepatitis C infection \u2014 Noninvasive assessment of liver fibrosis in the era of direct acting antivirals"],"prefix":"10.1016","volume":"51","author":[{"given":"Hirsh D.","family":"Trivedi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vilas R.","family":"Patwardhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raza","family":"Malik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.dld.2018.11.016_bib0005","first-page":"587","article-title":"Noninvasive assessment of fibrosis regression in hepatitis C virus sustained virologic responders","volume":"13","author":"Trivedi","year":"2017","journal-title":"Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.dld.2018.11.016_bib0010","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/apt.14011","article-title":"Editorial: combining elastography with blood test for fibrosis assessment in chronic hepatitis C","volume":"45","author":"Trivedi","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2018.11.016_bib0015","first-page":"2296","article-title":"Use of liver imaging and biopsy in clinical practice","author":"Tapper","year":"2017","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.dld.2018.11.016_bib0020","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1056\/NEJM200102153440706","article-title":"Liver biopsy","volume":"344","author":"Bravo","year":"2001","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.dld.2018.11.016_bib0025","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2012.02.017","article-title":"Noninvasive methods to assess liver disease in patients with hepatitis B or C","volume":"142","author":"Castera","year":"2012","journal-title":"Gastroenterology"},{"issue":"8480","key":"10.1016\/j.dld.2018.11.016_bib0030","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0140-6736(86)90883-4","article-title":"Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver","volume":"1","author":"Maharaj","year":"1986","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.dld.2018.11.016_bib0035","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1111\/j.1572-0241.2002.06038.x","article-title":"Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection","volume":"97","author":"Regev","year":"2002","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.dld.2018.11.016_bib0040","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cld.2014.09.007","article-title":"Contemporary assessment of hepatic fibrosis","volume":"19","author":"Bonder","year":"2015","journal-title":"Clin Liver Dis"},{"issue":"2","key":"10.1016\/j.dld.2018.11.016_bib0045","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","author":"Wai","year":"2003","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.dld.2018.11.016_bib0050","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/hep.24105","article-title":"Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis","volume":"53","author":"Lin","year":"2011","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.dld.2018.11.016_bib0055","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.dld.2018.11.016_bib0060","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.21669","article-title":"FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection: comparison with liver biopsy and fibrotest","volume":"46","author":"Vallet-Pichard","year":"2007","journal-title":"Hepatology"},{"issue":"9262","key":"10.1016\/j.dld.2018.11.016_bib0065","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S0140-6736(00)04258-6","article-title":"Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study","volume":"357","author":"Imbert-Bismut","year":"2001","journal-title":"Lancet"},{"issue":"38","key":"10.1016\/j.dld.2018.11.016_bib0070","doi-asserted-by":"crossref","first-page":"10749","DOI":"10.3748\/wjg.v21.i38.10749","article-title":"Hepatitis C virus markers in infection by hepatitis C virus: in the era of directly acting antivirals","volume":"21","author":"Coppola","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2018.11.016_bib0075","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1471-230X-7-40","article-title":"Meta-analyses of FibroTest diagnostic value in chronic liver disease","volume":"7","author":"Poynard","year":"2007","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"10.1016\/j.dld.2018.11.016_bib0080","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jhep.2014.02.029","article-title":"Prospective evaluation of FibroTest(R), FibroMeter(R), and HepaScore(R) for staging liver fibrosis in chronic hepatitis B: comparison with hepatitis C","volume":"61","author":"Leroy","year":"2014","journal-title":"J Hepatol"},{"issue":"7","key":"10.1016\/j.dld.2018.11.016_bib0085","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1053\/j.gastro.2011.02.058","article-title":"Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C","volume":"140","author":"Vergniol","year":"2011","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.dld.2018.11.016_bib0090","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/hep.20935","article-title":"A novel panel of blood markers to assess the degree of liver fibrosis","volume":"42","author":"Cales","year":"2005","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.dld.2018.11.016_bib0095","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jhep.2011.05.024","article-title":"Comparison of nine blood tests and transient elastography for liver fibrosis in chronic hepatitis C: the ANRS HCEP-23 study","volume":"56","author":"Zarski","year":"2012","journal-title":"J Hepatol"},{"issue":"11","key":"10.1016\/j.dld.2018.11.016_bib0100","doi-asserted-by":"crossref","first-page":"807","DOI":"10.7326\/0003-4819-158-11-201306040-00005","article-title":"Blood tests to diagnose fibrosis or cirrhosis in patients with chronic hepatitis C virus infection: a systematic review","volume":"158","author":"Chou","year":"2013","journal-title":"Ann Intern Med"},{"issue":"10","key":"10.1016\/j.dld.2018.11.016_bib0105","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1373\/clinchem.2005.048389","article-title":"Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection","volume":"51","author":"Adams","year":"2005","journal-title":"Clin Chem"},{"key":"10.1016\/j.dld.2018.11.016_bib0110","first-page":"972759","article-title":"Validation of hepascore as a predictor of liver fibrosis in patients with chronic hepatitis C infection","volume":"2011","author":"Kalantari","year":"2011","journal-title":"Hepat Res Treat"},{"issue":"7","key":"10.1016\/j.dld.2018.11.016_bib0115","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/ajg.2011.100","article-title":"A new combination of blood test and fibroscan for accurate non-invasive diagnosis of liver fibrosis stages in chronic hepatitis C","volume":"106","author":"Boursier","year":"2011","journal-title":"Am J Gastroenterol"},{"issue":"1\u20132","key":"10.1016\/j.dld.2018.11.016_bib0120","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.cca.2009.10.011","article-title":"Automation of the Hepascore and validation as a biochemical index of liver fibrosis in patients with chronic hepatitis C from the ANRS HC EP 23 Fibrostar cohort","volume":"411","author":"Guechot","year":"2010","journal-title":"Clin Chim Acta"},{"issue":"6","key":"10.1016\/j.dld.2018.11.016_bib0125","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.cgh.2009.01.010","article-title":"Validation of hepascore, compared with simple indices of fibrosis, in patients with chronic hepatitis C virus infection in United States","volume":"7","author":"Becker","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.dld.2018.11.016_bib0130","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1365-2036.2008.03742.x","article-title":"Optimized stepwise combination algorithms of non-invasive liver fibrosis scores including Hepascore in hepatitis C virus patients","volume":"28","author":"Bourliere","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.dld.2018.11.016_bib0135","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.jhep.2006.12.013","article-title":"Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C","volume":"46","author":"Leroy","year":"2007","journal-title":"J Hepatol"},{"issue":"11","key":"10.1016\/j.dld.2018.11.016_bib0140","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.3748\/wjg.v20.i11.2854","article-title":"Non-invasive diagnosis of liver fibrosis in chronic hepatitis C","volume":"20","author":"Schiavon Lde","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"12","key":"10.1016\/j.dld.2018.11.016_bib0145","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.ultrasmedbio.2003.07.001","article-title":"Transient elastography: a new noninvasive method for assessment of hepatic fibrosis","volume":"29","author":"Sandrin","year":"2003","journal-title":"Ultrasound Med Biol"},{"issue":"4","key":"10.1016\/j.dld.2018.11.016_bib0150","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jhep.2007.11.020","article-title":"Liver stiffness values in apparently healthy subjects: influence of gender and metabolic syndrome","volume":"48","author":"Roulot","year":"2008","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.dld.2018.11.016_bib0155","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1478-3231.2009.02172.x","article-title":"What are \u2018true normal\u2019 liver stiffness values using FibroScan?: a prospective study in healthy living liver and kidney donors in South Korea","volume":"30","author":"Kim","year":"2010","journal-title":"Liver Int"},{"issue":"3","key":"10.1016\/j.dld.2018.11.016_bib0160","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.dld.2010.07.008","article-title":"Normal liver stiffness and its determinants in healthy blood donors","volume":"43","author":"Colombo","year":"2011","journal-title":"Dig Liver Dis"},{"issue":"1","key":"10.1016\/j.dld.2018.11.016_bib0165","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/hep.20506","article-title":"Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C","volume":"41","author":"Ziol","year":"2005","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.dld.2018.11.016_bib0170","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1053\/j.gastro.2004.11.018","article-title":"Prospective comparison of transient elastography: fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C","volume":"128","author":"Castera","year":"2005","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.dld.2018.11.016_bib0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2012.10.044","article-title":"Discordance among transient elastography, aspartate aminotransferase to platelet ratio index, and histologic assessments of liver fibrosis in patients with chronic hepatitis C","volume":"11","author":"Gara","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.dld.2018.11.016_bib0180","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1111\/j.1440-1746.2010.06371.x","article-title":"Comparison of transient elastography: serum markers and clinical signs for the diagnosis of compensated cirrhosis","volume":"25","author":"Malik","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.dld.2018.11.016_bib0185","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.jhep.2010.05.035","article-title":"Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: a multicenter prospective study (the FIBROSTIC study)","volume":"53","author":"Degos","year":"2010","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.dld.2018.11.016_bib0190","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","article-title":"Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension","volume":"63","author":"de Franchis","year":"2015","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.dld.2018.11.016_bib0195","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s11894-014-0372-6","article-title":"Utilization of FibroScan in clinical practice","volume":"16","author":"Bonder","year":"2014","journal-title":"Curr Gastroenterol Rep"},{"issue":"8","key":"10.1016\/j.dld.2018.11.016_bib0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2012.01.015","article-title":"Levels of alanine aminotransferase confound use of transient elastography to diagnose fibrosis in patients with chronic hepatitis C virus infection","volume":"10","author":"Tapper","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.dld.2018.11.016_bib0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2014.09.046","article-title":"Diagnostic performance of magnetic resonance elastography in staging liver fibrosis: a systematic review and meta-analysis of individual participant data","volume":"13","author":"Singh","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.dld.2018.11.016_bib0210","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1053\/j.gastro.2008.03.076","article-title":"Magnetic resonance elastography for the noninvasive staging of liver fibrosis","volume":"135","author":"Huwart","year":"2008","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.dld.2018.11.016_bib0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2007.06.012","article-title":"Assessment of hepatic fibrosis with magnetic resonance elastography","volume":"5","author":"Yin","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2018.11.016_bib0220","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ejrad.2017.11.003","article-title":"MR elastography is effective for the non-invasive evaluation of fibrosis and necroinflammatory activity in patients with nonalcoholic fatty liver disease","volume":"98","author":"Costa-Silva","year":"2018","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.dld.2018.11.016_bib0225","article-title":"Diagnostic modalities for non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH) and associated fibrosis","author":"Younossi","year":"2017","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.dld.2018.11.016_bib0230","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jhep.2016.06.005","article-title":"MRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: clinical trials to clinical practice","volume":"65","author":"Dulai","year":"2016","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.dld.2018.11.016_bib0235","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2016.10.026","article-title":"Magnetic resonance elastography vs transient elastography in detection of fibrosis and noninvasive measurement of steatosis in patients with biopsy-proven nonalcoholic fatty liver disease","volume":"152","author":"Park","year":"2017","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.dld.2018.11.016_bib0240","doi-asserted-by":"crossref","first-page":"188","DOI":"10.4329\/wjr.v3.i7.188","article-title":"Is ARFI elastography reliable for predicting fibrosis severity in chronic HCV hepatitis?","volume":"3","author":"Sporea","year":"2011","journal-title":"World J Radiol"},{"issue":"12","key":"10.1016\/j.dld.2018.11.016_bib0245","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.1016\/j.ejrad.2012.08.018","article-title":"Acoustic radiation force impulse elastography for fibrosis evaluation in patients with chronic hepatitis C: an international multicenter study","volume":"81","author":"Sporea","year":"2012","journal-title":"Eur J Radiol"},{"issue":"2","key":"10.1016\/j.dld.2018.11.016_bib0250","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1148\/radiol.2523081928","article-title":"Liver fibrosis in viral hepatitis: noninvasive assessment with acoustic radiation force impulse imaging versus transient elastography","volume":"252","author":"Friedrich-Rust","year":"2009","journal-title":"Radiology"},{"issue":"12","key":"10.1016\/j.dld.2018.11.016_bib0255","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1038\/ajg.2011.341","article-title":"Comparison of transient elastography and acoustic radiation force impulse for non-invasive staging of liver fibrosis in patients with chronic hepatitis C","volume":"106","author":"Rizzo","year":"2011","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"10.1016\/j.dld.2018.11.016_bib0260","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.3748\/wjg.v18.i10.1077","article-title":"Evaluation of acoustic radiation force impulse imaging for determination of liver stiffness using transient elastography as a reference","volume":"18","author":"Kircheis","year":"2012","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.dld.2018.11.016_bib0265","first-page":"303","article-title":"Performance of a new elastographic method (ARFI technology) compared to unidimensional transient elastography in the noninvasive assessment of chronic hepatitis C. Preliminary results","volume":"18","author":"Lupsor","year":"2009","journal-title":"J Gastrointestin Liver Dis"},{"issue":"4","key":"10.1016\/j.dld.2018.11.016_bib0270","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1478-3231.2009.02130.x","article-title":"Evaluation of acoustic radiation force impulse elastography for fibrosis staging of chronic liver disease: a pilot study","volume":"30","author":"Takahashi","year":"2010","journal-title":"Liver Int"},{"issue":"44","key":"10.1016\/j.dld.2018.11.016_bib0275","doi-asserted-by":"crossref","first-page":"5525","DOI":"10.3748\/wjg.15.5525","article-title":"Acoustic radiation force imaging sonoelastography for noninvasive staging of liver fibrosis","volume":"15","author":"Fierbinteanu-Braticevici","year":"2009","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.dld.2018.11.016_bib0280","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1055\/s-0029-1245244","article-title":"Measurement of liver elasticity with acoustic radiation force impulse (ARFI) technology: an alternative noninvasive method for staging liver fibrosis in viral hepatitis","volume":"31","author":"Goertz","year":"2010","journal-title":"Ultraschall Med"},{"issue":"3","key":"10.1016\/j.dld.2018.11.016_bib0285","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S1665-2681(19)31639-4","article-title":"Comparison of acoustic radiation force impulse imaging (ARFI) to liver biopsy histologic scores in the evaluation of chronic liver disease: a pilot study","volume":"9","author":"Haque","year":"2010","journal-title":"Ann Hepatol"},{"issue":"Suppl 1","key":"10.1016\/j.dld.2018.11.016_bib0290","first-page":"S46","article-title":"Acoustic radiation force impulse elastography as compared to transient elastography and liver biopsy in patients with chronic hepatopathies","volume":"32","author":"Sporea","year":"2011","journal-title":"Ultraschall Med"},{"issue":"2","key":"10.1016\/j.dld.2018.11.016_bib0295","doi-asserted-by":"crossref","first-page":"e212","DOI":"10.1111\/j.1365-2893.2011.01537.x","article-title":"Performance of acoustic radiation force impulse imaging for the staging of liver fibrosis: a pooled meta-analysis","volume":"19","author":"Friedrich-Rust","year":"2012","journal-title":"J Viral Hepat"},{"issue":"1","key":"10.1016\/j.dld.2018.11.016_bib0300","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1148\/radiol.13122208","article-title":"Liver fibrosis: noninvasive assessment with acoustic radiation force impulse elastography \u2014 comparison with FibroScan M and XL probes and FibroTest in patients with chronic liver disease","volume":"269","author":"Cassinotto","year":"2013","journal-title":"Radiology"},{"issue":"7","key":"10.1016\/j.dld.2018.11.016_bib0305","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.ultrasmedbio.2012.02.032","article-title":"Intra- and interoperator reproducibility of acoustic radiation force impulse (ARFI) elastography \u2014 preliminary results","volume":"38","author":"Bota","year":"2012","journal-title":"Ultrasound Med Biol"},{"issue":"2","key":"10.1016\/j.dld.2018.11.016_bib0310","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/hep.28337","article-title":"Magnetic resonance elastography is superior to acoustic radiation force impulse for the diagnosis of fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease: a prospective study","volume":"63","author":"Cui","year":"2016","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.dld.2018.11.016_bib0315","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1111\/jgh.13788","article-title":"Improvement of liver stiffness in patients with hepatitis C virus infection who received direct-acting antiviral therapy and achieved sustained virological response","volume":"32","author":"Tada","year":"2017","journal-title":"J Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.dld.2018.11.016_bib0320","doi-asserted-by":"crossref","first-page":"e0195173","DOI":"10.1371\/journal.pone.0195173","article-title":"Shear wave elastography predicts hepatocellular carcinoma risk in hepatitis C patients after sustained virological response","volume":"13","author":"Hamada","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.dld.2018.11.016_bib0325","doi-asserted-by":"crossref","first-page":"64","DOI":"10.4254\/wjh.v9.i1.64","article-title":"Shear wave elastography in hepatitis C patients before and after antiviral therapy","volume":"9","author":"Suda","year":"2017","journal-title":"World J Hepatol"},{"issue":"6","key":"10.1016\/j.dld.2018.11.016_bib0330","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1002\/hep.22859","article-title":"SAFE biopsy: a validated method for large-scale staging of liver fibrosis in chronic hepatitis C","volume":"49","author":"Sebastiani","year":"2009","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.dld.2018.11.016_bib0335","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1365-2893.2006.00736.x","article-title":"Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies","volume":"13","author":"Bourliere","year":"2006","journal-title":"J Viral Hepat"},{"issue":"2","key":"10.1016\/j.dld.2018.11.016_bib0340","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jhep.2009.11.008","article-title":"Prospective comparison of two algorithms combining non-invasive methods for staging liver fibrosis in chronic hepatitis C","volume":"52","author":"Castera","year":"2010","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.dld.2018.11.016_bib0345","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/hep.24654","article-title":"Comparison of eight diagnostic algorithms for liver fibrosis in hepatitis C: new algorithms are more precise and entirely noninvasive","volume":"55","author":"Boursier","year":"2012","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.dld.2018.11.016_bib0350","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/apt.13954","article-title":"Liver fibrosis diagnosis by blood test and elastography in chronic hepatitis C: agreement or combination?","volume":"45","author":"Cales","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.dld.2018.11.016_bib0355","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/apt.14204","article-title":"Effectiveness of 8- or 12-weeks of ledipasvir and sofosbuvir in real-world treatment-naive, genotype 1 hepatitis C infected patients","volume":"46","author":"Curry","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.dld.2018.11.016_bib0360","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/jvh.12611","article-title":"Real-world effectiveness for 12 weeks of ledipasvir-sofosbuvir for genotype 1 hepatitis C: the Trio Health study","volume":"24","author":"Tapper","year":"2017","journal-title":"J Viral Hepat"},{"issue":"6","key":"10.1016\/j.dld.2018.11.016_bib0365","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1002\/hep.28782","article-title":"Evaluation of proton pump inhibitor use on treatment outcomes with ledipasvir and sofosbuvir in a real-world cohort study","volume":"64","author":"Tapper","year":"2016","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.dld.2018.11.016_bib0370","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.cgh.2013.07.034","article-title":"Liver stiffness is associated with risk of decompensation, liver cancer, and death in patients with chronic liver diseases: a systematic review and meta-analysis","volume":"11","author":"Singh","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.dld.2018.11.016_bib0375","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1053\/j.gastro.2015.05.010","article-title":"Ledipasvir and sofosbuvir plus ribavirin for treatment of HCV infection in patients with advanced liver disease","volume":"149","author":"Charlton","year":"2015","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.dld.2018.11.016_bib0380","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1093\/cid\/civ396","article-title":"Long-term treatment outcomes of patients infected with hepatitis C virus: a systematic review and meta-analysis of the survival benefit of achieving a sustained virological response","volume":"61","author":"Simmons","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.dld.2018.11.016_bib0385","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jhep.2014.02.022","article-title":"Baseline gamma-glutamyl transferase levels strongly correlate with hepatocellular carcinoma development in non-cirrhotic patients with successful hepatitis C virus eradication","volume":"61","author":"Huang","year":"2014","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.dld.2018.11.016_bib0390","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/hep.29115","article-title":"Risk of end-stage liver disease: hepatocellular carcinoma, and liver-related death by fibrosis stage in the hepatitis C Alaska Cohort","volume":"66","author":"Bruden","year":"2017","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.dld.2018.11.016_bib0395","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jhep.2016.05.027","article-title":"Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension","volume":"65","author":"Mandorfer","year":"2016","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.dld.2018.11.016_bib0400","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2017.07.016","article-title":"Effects of all-oral anti-viral therapy on HVPG and systemic hemodynamics in patients with hepatitis C virus-associated cirrhosis","volume":"153","author":"Lens","year":"2017","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.dld.2018.11.016_bib0405","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1111\/liv.13707","article-title":"Persistence of hepatocellular carcinoma risk in hepatitis C patients with a response to IFN and cirrhosis regression","volume":"38","author":"D\u2019Ambrosio","year":"2018","journal-title":"Liver Int"},{"issue":"10","key":"10.1016\/j.dld.2018.11.016_bib0410","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.cmi.2016.09.017","article-title":"Role of assessing liver fibrosis in management of chronic hepatitis C virus infection","volume":"22","author":"Carmona","year":"2016","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"10.1016\/j.dld.2018.11.016_bib0415","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jhep.2013.03.013","article-title":"The diagnostic accuracy of Fibroscan for cirrhosis is influenced by liver morphometry in HCV patients with a sustained virological response","volume":"59","author":"D\u2019Ambrosio","year":"2013","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.dld.2018.11.016_bib0420","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/hep.27950","article-title":"Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus","volume":"62","year":"2015","journal-title":"Hepatology"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865818312350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865818312350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:09:48Z","timestamp":1761624588000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865818312350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":84,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S1590865818312350"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2018.11.016","relation":{},"ISSN":["1590-8658"],"issn-type":[{"type":"print","value":"1590-8658"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic hepatitis C infection \u2014 Noninvasive assessment of liver fibrosis in the era of direct acting antivirals","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2018.11.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}